Among them, the c-MET/HGF-activated pathway is one of the most studied: its deregulation or constitutive activation is associated with cancer onset and progression, and for this reason, it has been considered as a potential target for therapeutic purpose in several solid cancers [7]. The gene discussed is HGF; the disease is cancer.